索引超出了数组界限。
[1] Inohara N, del Peso L, Koseki T, et al. RICK, a novel protein
kinase containing a caspase recruitment domain, interacts with
CLARP and regulates CD95-mediated apoptosis[J]. J Biol
Chem, 1998, 273(20):12296-12300.
[2] Gong Q, Long ZQ, Zhong FL, et al. Structural basis of RIP2
activation and signaling[J]. Nat Commun, 2018, 9(1):4993.
[3] Pellegrini E, Desfosses A, Wallmann A, et al. RIP2
filament formation is required for NOD2 dependent NF-κB
signalling[J]. Nat Commun, 2018, 9(1):4043.
[4] Shehat MG, Cardona OA, Aranjuez GF, et al. RIP2 promotes
FcγR-mediated reactive Oxygen species production[J]. J Biol
Chem, 2019, 294(26):10365-10378.
[5] Olona A, Leishman S, Anand PK. The NLRP3 inflammasome:
regulation by metabolic signals[J]. Trends Immunol, 2022,
43(12):978-989.
[6] Huang B, Gui M, Ni Z, et al. Chemotherapeutic drugs induce
different gut microbiota disorder pattern and NOD/RIP2/NF-
κB signaling pathway activation that lead to different degrees
of intestinal injury[J]. MicrobiolSpectr, 2022, 10(6):e0167722.
[7] Rahman MA, Sundaram K, Mitra S, et al. Receptor interacting
protein-2 plays a critical role in human lung epithelial cells
survival in response to Fas-induced cell-death[J]. PLoS One,
2014, 9(3):e92731.
[8] Kisiswa L, Fernández-Suárez D, Sergaki MC, et al. RIP2
gates TRAF6 interaction with death receptor p75NTR to
regulate cerebellar granule neuron survival[J]. Cell Rep, 2018,
24(4):1013-1024.
[9] Homer CR, Kabi A, Marina-García N, et al. A dual role for
receptor-interacting protein kinase 2 (RIP2) kinase activity
in nucleotide-binding oligomerization domain 2 (NOD2)-
dependent autophagy[J]. J Biol Chem, 2012, 287(30):25565-
25576.
[10] Shao Y, Saredy J, Yang WY, et al. Vascular endothelial cells
and innate immunity[J]. Arterioscler Thromb Vasc Biol, 2020,
40(6):e138-e152.
[11] Moreno L, McMaster SK, Gatheral T, et al. Nucleotide
oligomerization domain 1 is a dominant pathway for NOS2
induction in vascular smooth muscle cells: comparison
with Toll-like receptor 4 responses in macrophages[J]. Br J
Pharmacol, 2010, 160(8):1997-2007.
[12] Reed DM, Foldes G, Gatheral T, et al. Pathogen sensing
pathways in human embryonic stem cell derived-endothelial
cells: role of NOD1 receptors[J]. PLoS One, 2014,
9(4):e91119.
[13] González-Ramos S, Paz-García M, Rius C, et al. Endothelial
NOD1 directs myeloid cell recruitment in atherosclerosis
through VCAM-1[J]. FASEB J, 2019, 33(3):3912-3921.
[14] Suebsuwong C, Dai B, Pinkas DM, et al. Receptorinteracting
protein kinase 2 (RIPK2) and nucleotide-binding
oligomerization domain (NOD) cell signaling inhibitors based
on a 3,5-diphenyl-2-aminopyridine scaffold[J]. Eur J Med
Chem, 2020, 200:112417.
[15] Jacquet S, Nishino Y, Kumphune S, et al. The role of RIP2 in
p38 MAPK activation in the stressed heart[J]. J Biol Chem,
2008, 283(18):11964-11971.
[16] Sicard P, Jacquet S, Kobayashi KS, et al. Pharmacological
postconditioning effect of muramyl dipeptide is mediated
through RIP2 and TAK1[J]. Cardiovasc Res, 2009, 83(2):277-
284.
[17] Andersson L, ScharinT?ng M, Lundqvist A, et al. Rip2
modifies VEGF-induced signalling and vascular permeability
in myocardial ischaemia[J]. Cardiovasc Res, 2015, 107(4):478-
486.
[18] Li LP, Wang XD, Chen W, et al. Regulatory role of CARD3 in
left ventricular remodelling and dysfunction after myocardial
infarction[J]. Basic Res Cardiol, 2015, 110(6):56.
[19] Zhao CH, Ma X, Guo HY, et al. RIP2 deficiency attenuates
cardiac hypertrophy, inflammation and fibrosis in pressure
overload induced mice[J]. Biochem Biophys Res Commun,
2017, 493(2):1151-1158.
[20] Lin HB, Naito K, Oh Y, et al. Innate immune nod1/
RIP2 signaling is essential for cardiac hypertrophy but
requires mitochondrial antiviral signaling protein for signal
transductions and energy balance[J]. Circulation, 2020,
142(23):2240-2258.